![]() Rigani Press Announces BioCT's Inaugural Book Event Featuring Dr. S. Yin HoBioCT CEO Jodie Gillon to lead a fireside chat with Dr. S. Yin Ho about lessons from her book Rushing Headlong and the promise of responsible AI in healthcare at BioLabs in New Haven, Connecticut.
By: Rigani Press "What happens when health IT moves fast—but not thoughtfully enough?" asks Gillon. The conversation will explore key insights from Dr. Ho's book, which examines how missed opportunities, regulatory capture, and fragmented leadership have left healthcare systems with a health IT system that doesn't serve patients or physicians well. Together, Gillon and Ho will discuss how generative AI—used ethically and developed responsibly— Rushing Headlong challenges conventional wisdom about health technology while outlining a constructive path forward for innovation. This event invites healthcare professionals, entrepreneurs, academics, and technology leaders to join a timely discussion on ensuring that AI in healthcare serves both patients and society. Event Details: Date: Thursday, February 5, 2026 Time: 4:30 p.m. ET Location: BioLabs HQ, New Haven, CT Pre-registration required (https://luma.com/ About BioCT BioCT's mission is to catalyze and accelerate growth in the life sciences with the goal of improving human health, by fostering a rich, innovative ecosystem and promoting Connecticut as a preferred destination for life sciences exploration and innovation. About S. Yin Ho, MD, MBA S. Yin Ho, MD, MBA has spent more than two decades at the forefront of health information technology, clinical research, and digital health innovation. A Yale-trained emergency physician with an MBA from Harvard Business School, she has led health IT initiatives at Pfizer, Medidata, and Aetion. She founded the health economics analytics technology firm Context Matters (later acquired by Clarivate), and most recently served as interim CEO of Veradigm, where she spearheaded a key acquisition to develop health-specific generativeAI models with electronic health records to support clinical research. End
|